Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
6.25
+0.13 (2.12%)
Feb 3, 2026, 4:00 PM EST
SHA:688373 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 368.85 | 386.26 | 166.31 | 151.09 | 145.52 | 226.51 |
Trading Asset Securities | 114.86 | 207.36 | 786.98 | 1,119 | 326.36 | 410.45 |
Cash & Short-Term Investments | 483.71 | 593.62 | 953.3 | 1,270 | 471.88 | 636.96 |
Cash Growth | -34.66% | -37.73% | -24.95% | 169.17% | -25.92% | 1110.55% |
Accounts Receivable | 38.59 | 31.88 | 21.98 | 11.1 | 1.42 | - |
Other Receivables | 20.73 | 21.02 | 0.19 | 0.34 | 0 | 4.93 |
Receivables | 59.31 | 52.9 | 22.17 | 11.44 | 1.42 | 4.93 |
Inventory | 46.88 | 52.94 | 37.52 | 21.89 | 11.01 | 5.61 |
Other Current Assets | 50.15 | 49.21 | 41.27 | 67.01 | 25.29 | 14.5 |
Total Current Assets | 640.05 | 748.66 | 1,054 | 1,371 | 509.59 | 662 |
Property, Plant & Equipment | 65.08 | 75.8 | 86.21 | 97.46 | 122.8 | 1.02 |
Other Intangible Assets | 1.09 | 1.68 | 1.93 | 2.19 | 0.84 | 0.13 |
Long-Term Deferred Charges | 16.81 | 19.1 | 21.75 | 22.68 | 1.83 | 2.65 |
Other Long-Term Assets | 3.91 | 3.89 | 4.42 | 4.54 | 13.48 | 3.15 |
Total Assets | 726.93 | 849.13 | 1,169 | 1,497 | 648.54 | 668.94 |
Accounts Payable | 67.92 | 26.21 | 11.13 | 10.85 | 1.91 | - |
Accrued Expenses | 25.27 | 78.63 | 94.51 | 37.41 | 29.45 | 26.25 |
Short-Term Debt | 15 | 5 | - | 48.75 | 50.08 | 6.53 |
Current Portion of Long-Term Debt | 158.6 | 89.23 | 14.15 | 10.1 | - | - |
Current Portion of Leases | - | 11.51 | 10.38 | 6.47 | 11.04 | - |
Current Income Taxes Payable | - | - | 4.41 | - | - | - |
Current Unearned Revenue | - | - | 0.13 | - | - | - |
Other Current Liabilities | 9.61 | 1.71 | 1.93 | 1.52 | 1.71 | 0.44 |
Total Current Liabilities | 276.41 | 212.3 | 136.65 | 115.11 | 94.19 | 33.22 |
Long-Term Debt | 123.8 | 122.94 | 114.96 | 70 | - | - |
Long-Term Leases | 67.42 | 73.18 | 81.7 | 94.89 | 99.87 | - |
Long-Term Unearned Revenue | 1.75 | 1.75 | 1.25 | 3.1 | 16.1 | 15.5 |
Total Liabilities | 469.38 | 410.16 | 334.56 | 283.1 | 210.17 | 48.72 |
Common Stock | 655.61 | 655.61 | 655.21 | 655.21 | 525.21 | 525.21 |
Additional Paid-In Capital | 1,588 | 1,571 | 1,532 | 1,495 | 636.77 | 591.38 |
Retained Earnings | -1,998 | -1,805 | -1,364 | -942.85 | -722.55 | -496.28 |
Comprehensive Income & Other | 11.96 | 17.08 | 10.91 | 7.19 | -1.06 | -0.09 |
Shareholders' Equity | 257.55 | 438.96 | 834 | 1,214 | 438.37 | 620.23 |
Total Liabilities & Equity | 726.93 | 849.13 | 1,169 | 1,497 | 648.54 | 668.94 |
Total Debt | 364.82 | 301.86 | 221.19 | 230.21 | 160.99 | 6.53 |
Net Cash (Debt) | 118.89 | 291.76 | 732.11 | 1,040 | 310.88 | 630.43 |
Net Cash Growth | -72.75% | -60.15% | -29.60% | 234.52% | -50.69% | - |
Net Cash Per Share | 0.18 | 0.45 | 1.12 | 1.79 | 0.59 | 2.47 |
Filing Date Shares Outstanding | 655.61 | 655.61 | 655.21 | 655.21 | 525.21 | 525.21 |
Total Common Shares Outstanding | 655.61 | 655.61 | 655.21 | 655.21 | 525.21 | 525.21 |
Working Capital | 363.63 | 536.37 | 917.61 | 1,255 | 415.39 | 628.78 |
Book Value Per Share | 0.39 | 0.67 | 1.27 | 1.85 | 0.83 | 1.18 |
Tangible Book Value | 256.46 | 437.28 | 832.07 | 1,212 | 437.53 | 620.09 |
Tangible Book Value Per Share | 0.39 | 0.67 | 1.27 | 1.85 | 0.83 | 1.18 |
Machinery | - | 14.41 | 14.18 | 11.75 | 6.01 | 3.85 |
Construction In Progress | - | - | - | - | 15.65 | 0.35 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.